Phase 1B Study of Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

Conditions:   Autoimmune Diseases;   Non-small Cell Lung Cancer;   Rheumatoid Arthritis;   Psoriasis;   Giant Cell Arteritis;   Polymyalgia Rheumatica;   Systemic Lupus Erythematosus;   Crohn Disease;   Multiple Sclerosis;   Ulcerative Colitis Intervention:   Drug: Nivolumab Sponsors:   Alliance Foundation Trials, LLC.;   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials